Hostname: page-component-77c78cf97d-rv6c5 Total loading time: 0 Render date: 2026-04-23T23:43:54.746Z Has data issue: false hasContentIssue false
  • English
  • Français

The occurrence of hepatitis B and C viruses in Pakistani patients with chronic liver disease and hepatocellula carcinoma

Published online by Cambridge University Press:  15 May 2009

C. Y. W. Tong ,
R. Khan ,
N. J. Beeching ,
W. U. Z. Tariq ,
C. A. Hart ,
N. Ahmad  and
I. A. Malik
C. Y. W. Tong
Affiliation:
Department of Medical Microbiology, University of Liverpool, PO Box 147, Liverpool L69 3BX, UK
R. Khan
Affiliation:
Department of Medical Microbiology, University of Liverpool, PO Box 147, Liverpool L69 3BX, UK
N. J. Beeching
Affiliation:
Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, UK
W. U. Z. Tariq
Affiliation:
Armed Forces Institute of Pathology, Rawalpindi, Pakistan
C. A. Hart
Affiliation:
Department of Medical Microbiology, University of Liverpool, PO Box 147, Liverpool L69 3BX, UK
N. Ahmad
Affiliation:
Armed Forces Institute of Pathology, Rawalpindi, Pakistan
I. A. Malik
Affiliation:
Armed Forces Institute of Pathology, Rawalpindi, Pakistan
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

To study the occurrence of hepatitis B virus (HBV) and hepatitis C virus (HCV) in patients with chronic liver disease (CLD) and hepatocellular carcinoma (HCC) in Pakistan, blood samples from 105 sequential patients with biopsy-proven CLD (n = 82) and HCC (n = 23) were tested for HBV and HCV markers. Of the 105, 87 (83%) had evidence of hepatitis B exposure, 58 (55%) were positive for hepatitis B surface antigen (HBsAg), 23 (22%) had hepatitis C antibodies and 25 (24%) had detectable HCV RNA. Significantly more patients with HCC had evidence of HBV exposure in the absence of HCV markers (49/82 vs. 20/23, odds ratio 4·49,95 % CI 1·17–25·16). The proportion of patients positive for HBsAg with no HCV markers was also significantly higher in the HCC group (34/82 vs. 18/23, odds ratio 5·08, 95% CI 1·59—18·96). There were more patients with only HCV markers in the CLD group than the HCC group but the difference was not statistically significant (19/82 vs. 1/23, odds ratio 6·63, 95% CI 0·93—288·01). A modified non-isotopic restriction fragment length polymorphism study on PCR products was used to investigate the epidemiology of HCV genotypes in Pakistan. Due to depletion of the initial samples, a second series of specimens collected one year afterwards was used. Fifteen out of 40 samples had amplifiable product and all were identified as type 3. A commercial serological typing method on the same samples also confirmed that type 3 was the predominant HCV genotype in Pakistan.

Information

Type
Research Article
Information
Epidemiology & Infection , Volume 117 , Issue 2 , October 1996 , pp. 327 - 332
Copyright
Copyright © Cambridge University Press 1996

References

1.Hamasaki, K, Nakata, K, Tsutsumi, T, et al. Changes in the prevalence of hepatitis B and hepatitis C infection in patients with hepatocellular carcinoma in the Nagasaki prefecture, Japan. J Med Virol 1993; 40: 146–9.Google Scholar
2.Takano, S, Yokosuka, O, Imazeki, F, Tagawa, M, Omata, M. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: A prospective study of 251 patients. Hepatology 1995; 21: 650–4.Google Scholar
3.Robinson, WS. Hepatitis B virus and hepatitis delta virus. In: Mandell, GL, Douglas, RG, Bennett, TE, eds. Principles and practice of infectious diseases. New York: Churchill Livingstone, 1990: 1204–31.Google Scholar
4.Malik, IA, Luqman, M, Ahmad, A, et al. A clinicopathological study of viral hepatitis. Pakistan J Med Res 1987; 26: 4–11.Google Scholar
5.Malik, IA, Legters, LJ, Luqman, M, et al. The serological markers of hepatitis A and B in healthy population in northern Pakistan. J Pakistan M Assoc 1988; 38: 69–72.Google Scholar
6.Quraishi, MS, Zuberi, SJ, Ahmad, M. HBs-antigenaemia: Incidence in apparently healthy males. J Pakistan Med Assoc 1978; 28: 57.Google Scholar
7.Malik, IA, Tariq, WUZ. Viral hepatitis in Pakistan. Pakistan J Pathol 1993; 4: 1–5.Google Scholar
8.Cristiano, K, Di Bisceglie, AM, Hoofnagle, JH, Feinstone, SM. Hepatitis C viral RNA in serum of patients with chronic non-A, non-B hepatitis: detection by the polymerase chain reaction using multiple primer sets. Hepatology 1991; 14: 51–5.CrossRefGoogle ScholarPubMed
9.Kwok, S, Higashi, R. Avoiding false positives with PCR. Nature 1989; 339: 237–8.Google Scholar
10.McOmish, F, Yap, LP, Dow, BC, et al. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 1994; 32: 884–92.Google Scholar
11.Majid, A, Holmes, R, Desselberger, U, Simmonds, P, McKee, TA. Molecular epidemiology of hepatitis C virus infection amongst intravenous drug users in rural communities. J Med Virol 1995; 46: 48–51.CrossRefGoogle ScholarPubMed
12.Simmonds, P, Rose, KA, Graham, S, et al. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): Use of type-specific peptides to serologically differentiate infections with HCV types 1, 2 and 3. J Clin Microbiol 1993; 31: 1493–503.Google Scholar
13.Simmonds, P, Alberti, A, Alter, HJ, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19 (suppl): 1321–4.CrossRefGoogle ScholarPubMed
14.Paterlini, P, Gerken, G, Nakajima, E, et al. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med 1990; 323: 80–5.CrossRefGoogle ScholarPubMed
15.Linnen, J, Wages, J Jr, Zhang-Keck, Z-Y., et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmission agent. Science 1996; 271: 505–8.Google Scholar
16.Liaw, Y-F, Tsai, S-L, Chang, J-J, et al. Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis. Gastroenterology 1994; 106: 1048–53.Google Scholar
17.Sato, S, Fujiyama, S, Tanaka, M, et al. Co-infection of hepatitis C virus in patients with chronic hepatitis B infection. J Hepatol 1994; 21: 159–66.Google Scholar
18.Pontisso, P, Ruvoletto, MG, Fattovich, G, et al. Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology 1993; 105: 1529–33.Google Scholar
19.Mimms, LT, Mosley, JW, Hollinger, FB, et al. Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection. BMJ 1993; 307: 1095–7.Google Scholar
20.Hanley, JP, Dolan, G, Day, S, Skidmore, SJ, Irving, WI. Interaction of hepatitis B and hepatitis C infection in haemophilia. Br J Haematol 1993; 85: 611–2.CrossRefGoogle ScholarPubMed
21.Bukh, J, Miller, RH, Kew, MC, Purcell, RH. Hepatitis C virus RNA in southern African Blacks with hepatocellular carcinoma. Proc NatI Acad Sci 1993: 90; 1848–51.Google Scholar
22.Tsukuma, H, Hiyama, T, Tanaka, S, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Eng J Med 1993; 328: 1797–801.Google Scholar
23.Okuno, H, Xie, Z-C, Lu, B-Y, et al. A low prevalence of anti-hepatitis C virus antibody in patients with hepatocellular carcinoma in Guangxi Province, Southern China. Cancer 1994; 73: 58–62.Google Scholar
24.Kew, MC. Hepatitis C virus and hepatocellular carcinoma. FEMS Microbiol Rev 1994; 14: 211–20.Google Scholar
25.Blum, HE. Does hepatitis C virus cause hepatocellular carcinoma? Hepatology 1994; 19: 251–8.Google Scholar
26.Cuthbert, GJA. Hepatitis C: progress and problems. Clin Microbiol Rev 1994; 7: 505–32.Google Scholar
27.Simmonds, P. Variability of hepatitis C virus. Hepatology 1995; 21: 570–83.Google Scholar
28.Lau, JYN, Mizokami, M, Kolberg, JA, et al. Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J Infect Dis 1995; 171: 281–9.Google Scholar
29.Mahaney, K, Tedeschi, V, Maertens, G, et al. Genotypic analysis of hepatitis C virus in American patients. Hepatology 1994; 20: 1405–11.CrossRefGoogle ScholarPubMed
30.Dusheiko, G, Schmilovitz-Weiss, H, Brown, D, et al. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology 1994; 19: 13–7.CrossRefGoogle ScholarPubMed
31.Valliammai, T, Thyagarajan, SP, Zuckerman, AJ, Harrison, TJ. Diversity of genotypes of hepatitis C virus in southern India. J Gen Virol 1995; 76: 711–6.Google Scholar
32.Lam, JPH, McOmish, F, Burns, SM, Yap, PL, Mok, JYQ, Simmonds, P. Infrequent vertical transmission of hepatitis C virus. J Infect Dis 1993; 167: 572–6.Google Scholar
33.Narendranathan, M, Philip, M. Reusable needles – a major risk factor for acute virus B infection. Tropical Doctor 1993; 23: 64–6.Google Scholar